Examination of two sustained release nifedipine preparations in humans and in pigs

European Journal of Pharmaceutical Sciences

Volumn 4, Issue 6, 1996, Pages 351-357

  Kostewicz, Edmund ^a   Sansom, Lloyd ^a   Fishlock, Richard ^a   Morella, Angelo ^b   Kuchel, Timothy ^c  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b Faulding   (Australia)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Bioavailability; Nifedipine; Pig; Sustained release

Indexed keywords

NIFEDIPINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG RELEASE; FEMALE; HUMAN; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION; SWINE;

EID: 0030297081     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(96)00173-X     Document Type: Article

References (18)

1. Argenzio, R.A. and Southworth, M. (1974) Sites of Organic Acid Production and Absorption in Gastrointestinal Tract of the Pig. Am. J. Physiol. 228(2), 454-460.
2. Barr, W.H. (1972) The use of Physical and Animal Models to Asses Bioavailability. Pharmacology 8, 55-101
3. Chung, M., Reitberg, D.P., Gaffney, M. and Singleton, W. (1987) Clinical Pharmacokinetics of Nifedipine Gastrointestinal Therapeutic System -A Controlled-Release Formulation of Nifedipine. Am. J. Med. 83 (Suppl 6B), 10-14.
4. Dressman, J. and Yamanda, K. (1991) Animal models for oral drug absorption. In: Pharmaceutical Bioequivalence, Vol. 48, P.G. Welling, F.L.S. Tse, and S.V. Dighe (Eds), Dekker, New York, NY, 1991, pp 235-266.
5. Higuchi, W., Ho, N.F.H., Park, J.Y. and Komiya, I. (1981) Rate-limiting Steps and Factors in Drug Absorption. In: Prescott, L.F. and Nimmo, W.S. (Eds.) Drug Absorption. The Proceedings on the International Conference on Drug Absorption. Adis Press, Australia, pp 35-60.
6. Kleinbloesem, C.H., van Brummelen, P., van de Linde, J.A., Voogd, P.J. and Breimer, D.D. (1984) Nifedipine: Kinetics and dynamics in healthy subjects. Clin. Pharmacol. Ther. 35(6), 742-749.
7. Kleinbloesem, C.H., van Brummelen P., Danhof, M., Faber, H., Urquhart, J., and Breimer, D.D. (1987) Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans. Clin. Pharmacol. Ther. 41(1), 26-30.
8. Koritz, G.D. Bourne, D.W.A., Hunt, J.P., Prasad, V.I., Bevill, R.F and Gautam, S.R. (1981) Pharmacokinetics of theophylline in swine: a potential model for human drug bioavailability studies. J. Vet. Pharmacol. Ther. 4(3), 233-239.
9. Krishnan, T.R. and Abraham, I. (1994) Comparative Bioavailability of Clofazimine Coevaporate in the Pig. Biopharm. Drug Disposit. 15, 329-339.
10. Kwei, G.Y., Novak, L.B., Hettrick, L.A., Reiss, E.R., Ostovic, D., Loper, A.E., Lui, C.Y., Higgins, R.J., Chen, I. And Lin, J.H. (1995) Regiospecific Intestinal Absorption of the HIV Protease Inhibitor L-735,524 in Beagle Dogs. Pharm. Res. 12(6), 884-888.
11. Lennernas, H. (1994) Gastrointestinal absorption mechanisms: a comparison between animal and human models. Eur. J. Pharm. Sci. 2, 39-43.
12. Murdoch, D. and Brogden, R.N. (1991) Sustained Release Nifedipine Formulations: An Appraisal of their Current Uses and Prospective Roles in the Treatment of Hypertension, Ischaemic Heart Disease and Peripheral Vascular Disorders. Drugs 41(5), 737-779.
13. Ogata, H., Aoyagi, N., Kaniwa, N., Koibuchi, M., Shibazaki, T., Ejima, A., Shimamoto, T., Yashiki, T., Ogawa, Y., Uda, Y. and Nishida, Y. (1982) Correlation of the bioavailability of diazepam from uncoated tablets in beagle dogs with its dissolution rate and bioavailability in humans. Int. J. Clin. Pharmacol. Ther. Toxicol. 20(12), 576-581.
14. Palka, E., Vodopivec, P. and Japelj, M. (1985) Bioavailability of Various Nifedipine Dosing Forms in Beagle Dogs. Magyar, K., Szuts, T., Vereczkey, L. (Eds) Proc. 4th Cong. Hung. Pharmacol. Soc. Budapest vol 2. Sect. 4 Pharmacokinetics and Drug Metab. 2, pp. 435-440.
15. Reid, J.L., Meredith, P.A., Donnelly, R. and Elliott, H.L. (1988) Pharmacokinetics of Calcium Antagonists. J. Cardiovasc. Pharmacol. 12(Suppl. 7), S22-S26.
16. Shui, G.K., Sager, A.O., Velagapudi, R.B., Prasad, V.K. and Skelly, J.P. (1988) The Effect of Food on the Absorption of Controlled-Release Theophylline in Mini-Swine. Pharm. Res. 5(1), 48-52.
17. Sorkin, E.M., Clissold, S.P. and Brogden, R.N. (1985) Nifedipine. A review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy, in Ischaemic Heart Disease, Hypertension and Related Cardiovascular Disorders. Drugs 30, 182-274.
18. Tse, F.L.S. and Szeto, D.W. (1982) Theophylline Bioavailability in the Dog. J. Pharm. Sci. 71(11), 1301-1303.